Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084142 · ClinicalTrials.gov registry record · NA
Developing a Digital Aid to Improve ICD Decisions
A NA study of Heart Failure and Reduced Ejection Fraction, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT07084142: Recruiting NA study of Heart Failure and Reduced Ejection Fraction, sponsored by Stanford University.
NCT07084142 is a NA study of Heart Failure and Reduced Ejection Fraction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07084142, a NA study of Heart Failure and Reduced Ejection Fraction, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activity. While placement of an Implantable Cardioverter-Defibrillator (ICD) in a patient's chest can help prevent sudden cardiac death, these devices have several important downsides. This protocol focuses on development of a digital decision aid that helps heart failure patients make informed decisions that balance the benefits and downsides of ICD placement. This protocol covers the use of participant surveys, focus groups, and interviews to obtain the needed background information to guide the development of this digital tool, which will be subsequently tested against usual care in a randomized clinical trial. The study design is best described as a mixed methods evaluation and refinement of a digital app to improve ICD decision-making. In the future, the present protocol will be modified to create a new protocol that covers the needed human subjects requirements for performance of this clinical trial.
Primary Outcome
The Decisional Conflict Scale is a validated, 16-item questionnaire scale assessing whether a participant feels conflicted regarding a past medical decision. The range is 0 to 100 with higher scores indicating more conflict, a negative outcome.
Conditions Studied
Interventions
- OTHER Online, patient-facing decision-making aid (app) with personalized risk information.
- DEVICE Implantable Cardioverter Defibrillator (ICD)
- OTHER Online, patient-facing decision-making app without personalized risk information.
Study Locations (2)
California
- University of California, San Francisco - San Francisco
North Carolina
- Eastern Carolina University - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-08 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07084142 shows while recruiting
NCT07084142 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Heart Failure and Reduced Ejection Fraction appearing as the primary indexed condition, and to 3 interventions - of which Online, patient-facing decision-making aid (app) with personalized risk information. is the first listed.
NCT07084142 reports a single indexed study location in California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07084142 about?
NCT07084142 is a clinical study titled "Developing a Digital Aid to Improve ICD Decisions". Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged heart develops an abnormal pattern of electrical conduction that can result in cessation of heart activi...
What is the current status of trial NCT07084142?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-08. Estimated completion is 2026-06.
What conditions does trial NCT07084142 study?
This clinical trial studies the following conditions: Heart Failure and Reduced Ejection Fraction.
What interventions are being tested in trial NCT07084142?
The interventions under investigation include: Online, patient-facing decision-making aid (app) with personalized risk information. (OTHER), Implantable Cardioverter Defibrillator (ICD) (DEVICE), Online, patient-facing decision-making app without personalized risk information. (OTHER).
Who is sponsoring clinical trial NCT07084142?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07084142 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure and Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07084142's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,828 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia